Enduring Exercise Habits: Trending Norms

June 9, 2020 updated by: University of Pennsylvania
Learning that most people engage in an activity can be a powerful motivator to adoption. But are there instances in which people can similarly find motivation from learning that only a minority of others engage in a behavior? Evidence suggests this may be possible when the message is that the size of the minority has been growing in recent years. In this study, we first examine how gym members' exercise patterns shift when they are informed that the minority versus the majority of (a subpopulation of) other Americans exercise frequently. We also test how gym members are affected by learning that the number of frequent exercisers has increased in recent years.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Gym members register online to participate in a 28-day workout program. Upon registration, participants are assigned to one of five conditions (a 2 x 2 study design plus a control group). Participants are assigned to receive information about majority exercise norms or minority exercise norms, and are informed that these norms are trending up or receive no information about trends in these norms. Participants are then prompted to create a workout schedule. Over the 28-day intervention period, participants are sent text messages with information about exercise depending on their condition (i.e., majority trending exercise norms, majority exercise norms with no information about trends, minority trending exercise norms or minority norms with no information about trends), workout reminders before their scheduled workouts, and weekly emails with additional exercise information related to their assigned condition and their schedule. Participants assigned to the control condition are prompted to create a workout schedule and receive text message reminders, information about exercise that is unrelated to social norms, and weekly emails with exercise information unrelated to social norms or trends and their workout schedule. All participants earn points for participating and for each day that they go to the gym which can be redeemed for an Amazon cash gift card after the end of the intervention period.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
2000

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Has 24 Hour Fitness gym membership

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Trending majority norm
Participants receive information about exercise-related norms that apply to the majority of the population and are told this norm has been increasing recently.
Behavioral: Trending Majority Norm
Participants receive information about exercise norms that apply to the majority of the population and have recently been trending up.
Experimental: Non-trending majority norm
Participants receive information about exercise-related norms that apply to the majority of the population but are not told about recent trends.
Behavioral: Majority Norm
Participants receive information about exercise norms that apply to the majority of the population but are given no information about trends in this norm.
Experimental: Trending minority norm
Participants receive information about exercise-related norms that apply to a minority of the population and are told this norm has been increasing recently
Behavioral: Trending Minority Norm
Participants receive information about exercise norms that apply to the minority of the population and have recently been trending up.
Experimental: Non-trending minority norm
Participants receive information about exercise-related norms that apply to a minority of the population but are not told about recent trends.
Behavioral: Minority Norm
Participants receive information about exercise norms that apply to the minority of the population but are given no information about trends in this norm.
Experimental: Control
Participants receive information about exercise unrelated to social norms or recent trends.
Behavioral: Control
Participants receive information about exercise that is unrelated to social norms or trends in social norms.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Gym visits per week
Time Frame: During the 28-day intervention period
Number of times the participant goes to the gym
During the 28-day intervention period
Gym visits per week
Time Frame: During the 4-weeks post-intervention
Number of times the participant goes to the gym
During the 4-weeks post-intervention
Gym visits per week
Time Frame: During the 10-weeks post-intervention
Number of times the participant goes to the gym
During the 10-weeks post-intervention
Whether or not a participant visits the gym in a given week
Time Frame: During the 28-day intervention period
Binary variable capturing whether or not a participant had any gym visits in a given week
During the 28-day intervention period
Whether or not a participant visits the gym in a given week
Time Frame: During the 4-weeks post-intervention
Binary variable capturing whether or not a participant had any gym visits in a given week
During the 4-weeks post-intervention
Whether or not a participant visits the gym in a given week
Time Frame: During the 10-weeks post-intervention
Binary variable capturing whether or not a participant had any gym visits in a given week
During the 10-weeks post-intervention

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Gym visits per week
Time Frame: During the 52-weeks post-intervention
Number of times the participant goes to the gym
During the 52-weeks post-intervention
Whether or not a participant visits the gym in a given week
Time Frame: During the 52-weeks post-intervention
Binary variable capturing whether or not a participant had any gym visits in a given week
During the 52-weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 31, 2018

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 28, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 28, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 2, 2018

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 8, 2018

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 14, 2018

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 11, 2020

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 9, 2020

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 827107-1237

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings